616
Views
1
CrossRef citations to date
0
Altmetric
Abdominal and Gastrointestinal Radiology

Post-Processing of Dynamic Gadolinium-Enhanced Magnetic Resonance Imaging Exams of the Liver: Explanation and Potential Clinical Applications for Color-Coded Qualitative and Quantitative Analysis

, , , , &
Pages 6-18 | Accepted 05 Aug 2007, Published online: 09 Jul 2009

References

  • Hussain S. M., Semelka R. C. Liver masses. Magn Reson Imaging Clin N Am 2005; 13: 255–75
  • Mendez Romero A., Wunderink W., Hussain S. M., De Pooter J. A., Heijmen B. J., Nowak P. C., et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i–ii study. Acta Oncol 2006; 45: 831–7
  • Materne R., Van Beers B. E., Smith A. M., Leconte I., Jamart J., Dehoux J. P., et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000; 99: 517–25
  • Becker G. A., Muller-Schauenburg W., Spilker M. E., Machulla H. J., Piert M. A priori identifiability of a one-compartment model with two input functions for liver blood flow measurements. Phys Med Biol 2005; 50: 1393–404
  • Cosar S., Oktar S. O., Cosar B., Yucel C., Ozdemir H. Doppler and gray-scale ultrasound evaluation of morphological and hemodynamic changes in liver vascualture in alcoholic patients. Eur J Radiol 2005; 54: 393–9
  • Materne R., Smith A. M., Peeters F., Dehoux J. P., Keyeux A., Horsmans Y., et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002; 47: 135–42
  • Krix M., Plathow C., Kiessling F., Herth F., Karcher A., Essig M., et al. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol 2004; 30: 1355–63
  • Li J., Dong B. W., Yu X. L., Li C. F. Gray scale contrast enhancement and quantification in different positions of rabbit liver. J Ultrasound Med 2006; 25: 7–14
  • Burns P. N., Wilson S. R. Focal liver masses: enhancement patterns on contrast-enhanced images—concordance of US scans with CT scans and MR images. Radiology 2007; 242: 162–74
  • Bartolotta T. V., Taibbi A., Galia M., Runza G., Matranga D., Midiri M., et al. Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 2007; 17: 650–1
  • Bader T. R., Herneth A. M., Blaicher W., Steininger R., Muhlbacher F., Lechner G., et al. Hepatic perfusion after liver transplantation: noninvasive measurement with dynamic single-section CT. Radiology 1998; 209: 129–34
  • Pandharipande P. V., Krinsky G. A., Rusinek H., Lee V. S. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005; 234: 661–73
  • Planchamp C., Pastor C. M., Balant L., Becker C. D., Terrier F., Gex-Fabry M. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA. Invest Radiol 2005; 40: 705–14
  • Schwickert H. C., Roberts T. P., Shames D. M., Van Dijke C. F., Disston A., Muhler A., et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995; 34: 845–52
  • Wang Y. X., Hussain S. M., Krestin G. P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319–31
  • Glockner J. F. Hepatobiliary MRI: current concepts and controversies. J Magn Reson Imaging 2007; 25: 681–95
  • Hussain S. M., Semelka R. C. Hepatic imaging: comparison of modalities. Radiol Clin North Am 2005; 43: 929–47, ix
  • Hyslop W. B., Balci N. C., Semelka R. C. Future horizons in MR imaging. Magn Reson Imaging Clin N Am 2005; 13: 211–24
  • Pruessmann K. P., Weiger M., Scheidegger M. B., Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999; 42: 952–62
  • Sodickson D. K., Manning W. J. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997; 38: 591–603
  • Heidemann R. M., Griswold M. A., Seiberlich N., Kruger G., Kannengiesser S. A., Kiefer B., et al. Direct parallel image reconstructions for spiral trajectories using GRAPPA. Magn Reson Med 2006; 56: 317–26
  • Weiger M., Boesiger P., Hilfiker P. R., Weishaupt D., Pruessmann K. P. Sensitivity encoding as a means of enhancing the SNR efficiency in steady-state MRI. Magn Reson Med 2005; 53: 177–85
  • Wiesinger F., Van De Moortele P. F., Adriany G., De Zanche N., Ugurbil K., Pruessmann K. P. Potential and feasibility of parallel MRI at high field. NMR Biomed 2006; 19: 368–78
  • Goh V., Padhani A. R. Imaging tumor angiogenesis: functional assessment using MDCT or MRI?. Abdom Imaging 2006; 31: 194–9
  • Gandhi S. N., Brown M. A., Wong J. G., Aguirre D. A., Sirlin C. B. MR contrast agents for liver imaging: what, when, how. Radiographics 2006; 26: 1621–36
  • Broome D. R., Girguis M. S., Baron P. W., Cottrell A. C., Kjellin I., Kirk G. A. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 2007; 188: 586–92
  • Morana G., Grazioli L., Testoni M., Caccia P., Procacci C. Contrast agents for hepatic magnetic resonance imaging. Top Magn Reson Imaging 2002; 13: 117–50
  • Grazioli L., Morana G., Caudana R., Benetti A., Portolani N., Talamini G., et al. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 2000; 35: 25–34
  • Torheim G., Lombardi M., Rinck P. A. An independent software system for the analysis of dynamic MR images. Acta Radiol 1997; 38: 165–72
  • Ichikawa T., Erturk S. M., Araki T. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Eur J Radiol 2006; 58: 165–76
  • Choyke P. L., Dwyer A. J., Knopp M. V. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003; 17: 509–20
  • Totman J. J., O'Gorman R. L., Kane P. A., Karani J. B. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol 2005; 78: 105–9
  • Kuhl C. K., Mielcareck P., Klaschik S., Leutner C., Wardelmann E., Gieseke J., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999; 211: 101–10
  • Terkivatan T., Van Den Bos I. C., Hussain S. M., Wielopolski P. A., De Man R. A., IJzermans J. N. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. J Magn Reson Imaging 2006; 24: 864–72
  • Hussain S. M., Van Den Bos I. C., Dwarkasing R. S., Kuiper J. W., Den Hollander J. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006; 16: 1873–86
  • Hussain S. M., Semelka R. C., Mitchell D. G. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2002; 10: 31–52, v
  • Padhani A. R. Functional MRI for anticancer therapy assessment. Eur J Cancer 2002; 38: 2116–27
  • White M. J., O'Gorman R. L., Charles-Edwards E. M., Kane P. A., Karani J. B., Leach M. O., et al. Parametric mapping of the hepatic perfusion index with gadolinium-enhanced volumetric MRI. Br J Radiol 2007; 80: 113–20
  • Daldrup-Link H. E., Simon G. H., Brasch R. C. Imaging of tumor angiogenesis: current approaches and future prospects. Curr Pharm Des 2006; 12: 2661–72
  • Kanematsu M., Semelka R. C., Leonardou P., Mastropasqua M., Armao D., Vaidean G., et al. Angiogenesis in hepatocellular nodules: correlation of MR imaging and vascular endothelial growth factor. J Magn Reson Imaging 2004; 20: 426–34
  • Wang J., Chen L. T., Tsang Y. M., Liu T. W., Shih T. T. Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study. Am J Roentgenol 2004; 183: 713–9
  • Wang B., Gao Z. Q., Yan X. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma. Acta Radiol 2005; 46: 353–8
  • Kwak B. K., Shim H. J., Park E. S., Kim S. A., Choi D., Lim H. K., et al. Hepatocellular carcinoma: correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast-enhanced computed tomography. Invest Radiol 2001; 36: 487–92
  • Leach M. O., Brindle K. M., Evelhoch J. L., Griffiths J. R., Horsman M. R., Jackson A., et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol 2003; 76(Suppl 1)S87–91
  • Jackson A., Haroon H., Zhu X. P., Li K. L., Thacker N. A., Jayson G. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 2002; 15: 164–73
  • Morgan B., Thomas A. L., Drevs J., Hennig J., Buchert M., Jivan A., et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003; 21: 3955–64
  • Dawson P. Functional imaging in CT. Eur J Radiol 2006; 60: 331–40
  • Padhani A. R., Hayes C., Landau S., Leach M. O. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 2002; 15: 143–53
  • Lee L., Sharma S., Morgan B., Allegrini P., Schnell C., Brueggen J., et al. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother Pharmacol 2006; 57: 761–71
  • Kamel I. R., Bluemke D. A., Eng J., Liapi E., Messersmith W., Reyes D. K., et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006; 17: 505–12
  • Wersebe A., Wiskirchen J., Decker U., Schick F., Dietz K., Muller-Schimpfle M., et al. Comparison of gadolinium-BOPTA and ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient. Invest Radiol 2006; 41: 264–71
  • Xiong H. Q., Herbst R., Faria S. C., Scholz C., Davis D., Jackson E. F., et al. A phase I surrogate endpoint study of SU6668 in patients with solid tumors. Invest New Drugs 2004; 22: 459–66
  • Galbraith S. M., Lodge M. A., Taylor N. J., Rustin G. J., Bentzen S., Stirling J. J., et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002; 15: 132–42
  • Meijerink M. R., van Cruijsen H., Hoekman K., Kater M., Van Schaik C., Van Waesberghe J. H., et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol 2006; 17: 1700–13
  • Thomsen H. S., Morcos S. K. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 2006; 16: 1835–40
  • Shuke N., Aburano T., Okizaki A., Zhao C., Nakajima K., Yokoyama K., et al. Estimation of fractional liver uptake and blood retention of 99mTc-DTPA-galactosyl human serum albumin: an application of a simple graphical method to dynamic SPECT. Nucl Med Commun 2003; 24: 503–11
  • Nishiyama Y., Yamamoto Y., Hino I., Satoh K., Wakabayashi H., Ohkawa M. 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. Nucl Med Commun 2003; 24: 809–17
  • Flower M. A., Zweit J., Hall A. D., Burke D., Davies M. M., Dworkin M. J., et al. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med 2001; 28: 99–103
  • Tofts P. S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91–101
  • Li X., Rooney W. D., Springer C. S Jr. A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents. Magn Reson Med 2005; 54: 1351–9
  • Leach M. O., Brindle K. M., Evelhoch J. L., Griffiths J. R., Horsman M. R., Jackson A., et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005; 92: 1599–610
  • Lee T. Y., Purdie T. G., Stewart E. CT imaging of angiogenesis. Q J Nucl Med 2003; 47: 171–87
  • Johnson J. A., Wilson T. A. A model for capillary exchange. Am J Physiol 1966; 210: 1299–303
  • Kiessling F., Krix M., Heilmann M., Vosseler S., Lichy M., Fink C., et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography. Invest Radiol 2003; 38: 516–24
  • Futterer J. J., Heijmink S. W., Scheenen T. W., Veltman J., Huisman H. J., Vos P., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241: 449–58
  • Preda A., Van Vliet M., Krestin G. P., Brasch R. C., Van Dijke C. F. Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition. Invest Radiol 2006; 41: 325–31
  • Larsson H. B., Fritz-Hansen T., Rostrup E., Sondergaard L., Ring P., Henriksen O. Myocardial perfusion modeling using MRI. Magn Reson Med 1996; 35: 716–26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.